FILING ANALYSIS · MONDAY, OCTOBER 5
Alector, Inc. ALEC — 8-K: Entry into a Material Definitive Agreement
positive
Alector has entered into a License Agreement with Genentech, granting exclusive worldwide rights to develop and commercialize its AL050 program in exchange for a $100 million upfront payment and up to $1.17 billion in potential milestone payments, as well as tiered royalties on net sales. This deal significantly bolsters Alector's cash position, enabling it to fund operations into 2029.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →